New Zealand markets closed

Cullinan Therapeutics, Inc. (CGEM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.43-0.08 (-0.46%)
At close: 04:00PM EDT
17.43 0.00 (0.00%)
After hours: 04:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
18,943
0
-
Operating expenses
Research development
126,706
148,156
91,948
57,751
43,211
-
Selling general and administrative
44,176
42,493
40,189
29,146
17,124
-
Total operating expenses
170,882
190,649
132,137
86,897
60,335
-
Operating income or loss
-170,882
-190,649
-132,137
-67,954
-60,335
-
Total other income/expenses net
-352
-201
276,842
-8
-11
-
Income before tax
-148,422
-169,223
151,316
-67,485
-59,458
-
Income tax expense
-
-14,122
42,121
0
-
-
Income from continuing operations
-134,300
-155,101
109,195
-67,485
-59,458
-
Net income
-132,348
-153,162
111,214
-65,570
-51,799
-
Net income available to common shareholders
-132,348
-153,162
111,214
-65,570
-51,799
-
Basic EPS
-3.76
-
2.46
-1.52
-1.37
-1.07
Diluted EPS
-3.76
-
2.38
-1.52
-1.37
-1.07
Basic average shares
42,287
-
45,164
43,077
41,398
19,361
Diluted average shares
42,553
-
46,640
43,077
41,398
19,361